{
    "nctId": "NCT00007904",
    "briefTitle": "Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes",
    "officialTitle": "A Phase II Study Of Safety And Tolerability Of Adjuvant Chemotherapy With Continuous Infusion Paclitaxel And Dose Intense Cyclophosphamide And Hematopoietic Growth Factor Support Followed By Doxorubicin For Stage II-IIIA Breast Cancer Involving Greater Than or Equal to 10 Lymph Nodes",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 16,
    "primaryOutcomeMeasure": "To determine the safety of administering continuous infusion paclitaxel with dose intense cyclophosphamide",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Histologically confirmed stage II or IIIA breast cancer\n\n  * At least 5 axillary lymph nodes\n  * No T4 or N3 disease\n* No distant metastases by CT scan of the chest, abdomen, and pelvis; bone scan; and bone marrow evaluation\n* No more than 8 weeks since prior lumpectomy or mastectomy with axillary node dissection\n\n  * Negative surgical margins\n* Hormone receptor status:\n\n  * Hormone receptor status known\n\nPATIENT CHARACTERISTICS:\n\nAge:\n\n* 18 and over\n\nSex:\n\n* Male or female\n\nMenopausal status:\n\n* Not specified\n\nPerformance status:\n\n* ECOG 0-1\n\nLife expectancy:\n\n* Not specified\n\nHematopoietic:\n\n* WBC at least 3,500/mm\\^3\n* Granulocyte count at least 1,500/mm\\^3\n* Platelet count greater than 100,000/mm\\^3\n\nHepatic:\n\n* Bilirubin no greater than 1.5 times upper limit of normal (ULN)\n* SGOT no greater than 1.5 times ULN\n* Alkaline phosphatase no greater than 1.5 times ULN\n\nRenal:\n\n* Creatinine no greater than 1.5 mg/dL\n\nCardiovascular:\n\n* No poorly controlled ischemic heart disease or congestive heart failure\n\nPulmonary:\n\n* No severe chronic obstructive or restrictive pulmonary disease\n\nOther:\n\n* Not pregnant or nursing\n* Negative pregnancy test\n* Fertile patients must use effective contraception\n* No severe diabetes mellitus\n* No other severe concurrent medical or psychiatric illness that would preclude study participation\n* No other malignancy within past 5 years except curatively treated ductal carcinoma in situ, lobular carcinoma in situ, or breast cancer\n\nPRIOR CONCURRENT THERAPY:\n\nBiologic therapy:\n\n* Not specified\n\nChemotherapy:\n\n* No prior chemotherapy\n\nEndocrine therapy:\n\n* Not specified\n\nRadiotherapy:\n\n* No prior radiotherapy\n\nSurgery:\n\n* See Disease Characteristics",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}